Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets B Van Hout, MF Janssen, YS Feng, T Kohlmann, J Busschbach, D Golicki, ... Value in health 15 (5), 708-715, 2012 | 1924 | 2012 |
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study MF Janssen, AS Pickard, D Golicki, C Gudex, M Niewada, L Scalone, ... Quality of life research 22, 1717-1727, 2013 | 1547 | 2013 |
Validity of EQ-5D-5L in stroke D Golicki, M Niewada, J Buczek, A Karlińska, A Kobayashi, MF Janssen, ... Quality of life research 24, 845-850, 2015 | 245 | 2015 |
Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients D Golicki, M Niewada, A Karlińska, J Buczek, A Kobayashi, MF Janssen, ... Quality of Life Research 24, 1555-1563, 2015 | 149 | 2015 |
EQ-5D in central and Eastern Europe: 2000–2015 F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ... Quality of Life Research 25, 2693-2710, 2016 | 142 | 2016 |
Valuation of EQ‐5D Health States in Poland: First TTO‐based social value set in Central and Eastern Europe D Golicki, M Jakubczyk, M Niewada, W Wrona, JJV Busschbach Value in Health 13 (2), 289-297, 2010 | 137 | 2010 |
EQ-5D-5L Polish population norms D Golicki, M Niewada Pol Arch Med Sci 125 (1-2), 18-26, 2015 | 115 | 2015 |
Meta‐analysis: zinc supplementation for acute gastroenteritis in children B Patro, D Golicki, H Szajewska Alimentary pharmacology & therapeutics 28 (6), 713-723, 2008 | 109 | 2008 |
Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials A Szypowska, A Ramotowska, K Dzygalo, D Golicki Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2012 | 100 | 2012 |
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis DT Golicki, D Golicka, L Groele, E Pankowska Diabetologia 51, 233-240, 2008 | 97 | 2008 |
Valuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern Europe D Golicki, M Jakubczyk, K Graczyk, M Niewada Pharmacoeconomics 37, 1165-1176, 2019 | 85 | 2019 |
Modafinil for narcolepsy: systematic review and meta-analysis D Golicki, M Bała, M Niewada, A Wierzbicka Medical science monitor 16 (8), 2010 | 83 | 2010 |
Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary F Rencz, V Brodszky, L Gulácsi, D Golicki, G Ruzsa, AS Pickard, EH Law, ... Value in Health 23 (9), 1235-1245, 2020 | 81 | 2020 |
Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study D Golicki, M Niewada, M Jakubczyk, W Wrona, T Hermanowski Pol Arch Med Wewn 120 (7-8), 276-81, 2010 | 61 | 2010 |
General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland D Golicki, M Niewada Pol Arch Med Wewn 125 (1-2), 18-26, 2015 | 60 | 2015 |
The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus–systematic review A Ramotowska, D Golicki, K Dżygało, A Szypowska Experimental and Clinical Endocrinology & Diabetes 121 (05), 248-254, 2013 | 56 | 2013 |
Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials D Golicki, M Niewada, J Lis, K Pol, T Hermanowski, M Tlustochowicz Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2012 | 56 | 2012 |
Quality of life in patients with type 2 diabetes in Poland-comparison with the general population using the EQ-5D questionnaire M Dudzińska, A Zwolak, JS Tarach Advances in Clinical and Experimental Medicine 24 (1), 2015 | 55 | 2015 |
Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patients … MM Farkowski, M Pytkowski, A Maciag, D Golicki, KA Wood, I Kowalik, ... Europace 16 (12), 1821-1827, 2014 | 55 | 2014 |
Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes A Szypowska, D Golicki, L Groele, E Pankowska Pol Arch Med Wewn 121 (7-8), 237-246, 2011 | 49 | 2011 |